Joseph Shulman - Feb 9, 2023 Form 4/A - Amendment Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: Chief Technical Officer
Signature: /s/ Hunter Smith, attorney-in-fact for Joseph Shulman
Stock symbol: RYTM
Transactions as of: Feb 9, 2023
Transactions value $: -$25,612
Form type: 4/A - Amendment
Date filed: 2/14/2023, 06:26 PM
Date Of Original Report: Feb 13, 2023
Previous filing: Feb 3, 2023
Next filing: Feb 14, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RYTM	Common Stock	Sale	-$25.6K	-931	-25.42%	$27.51	2.73K	Feb 9, 2023	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Remarks:

This amended Form 4 is being filed solely for the purpose of correcting an administrative error in the number of shares sold and sale price which were initially reported on the Form 4 filed on February 13, 2023.